| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/27/1997 | EP0520005B1 Nitroxides for weight reduction |
| 08/27/1997 | EP0495781B1 Radiation synovectomy compositions |
| 08/27/1997 | EP0476066B1 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition |
| 08/27/1997 | EP0460116B1 9-substituted-8-unsubstituted-9-deazaguanines |
| 08/27/1997 | CN1158171A Current-to-pressure transducer with selectable, adjustable input filter |
| 08/27/1997 | CN1158130A Triazolopyridazines, their preparation and their use |
| 08/27/1997 | CN1158128A Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation method and compositions |
| 08/27/1997 | CN1158127A Novel N-substituted naphthofused lactams |
| 08/27/1997 | CN1158123A Benzoxazoles and pyridine derivatives useful in the treatment of the type II diabetes |
| 08/27/1997 | CN1158121A Indolizine SPLA2 inhibitors |
| 08/27/1997 | CN1158120A Process for making antimicrobial compounds |
| 08/27/1997 | CN1158119A Legionella specific antibiotic, a mcroorganism producing the antibiotic and a process for producing the same |
| 08/27/1997 | CN1158087A Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 08/27/1997 | CN1158086A Methods of inhibiting endometrial mitoses |
| 08/27/1997 | CN1158085A Composition alleviating pain, containing a non-napcotic and an analgesia enhancer |
| 08/27/1997 | CN1158084A Scopolamine plaster |
| 08/27/1997 | CN1158083A Patch for external use |
| 08/27/1997 | CN1157824A Azrinomycin dihydric phosphate complex salt and its preparation |
| 08/27/1997 | CN1157822A Pharmaceutical compounds |
| 08/27/1997 | CN1157821A Process for preparation of tetrazole derivatives |
| 08/27/1997 | CN1157818A 1 alpha, 26-dihydroxy-D-homo-vitamin D3 |
| 08/27/1997 | CN1157817A Material for elimination or detoxification of super antigens |
| 08/27/1997 | CN1157815A 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients |
| 08/27/1997 | CN1157720A Notoginsenoside powder injection |
| 08/27/1997 | CN1157719A Percutaneous applied medicine contained gestodene |
| 08/27/1997 | CN1157718A Method for reducing infarct size in subjects afflicted with ischemic heart disease |
| 08/27/1997 | CN1157717A Application of oxidized matrine in preparing medine for treatment of hepatitis B. |
| 08/27/1997 | CN1157716A Metastasis suppressory agents |
| 08/27/1997 | CA2198576A1 Pharmaceutical composition which comprises hirudin, and process for preparing it |
| 08/27/1997 | CA2198525A1 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism |
| 08/27/1997 | CA2197751A1 Growth promotion in chickens |
| 08/27/1997 | CA2170313A1 Method for treating emesis |
| 08/26/1997 | US5661188 Administering to prevent peritonitis following kidney transplantation |
| 08/26/1997 | US5661187 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals |
| 08/26/1997 | US5661184 Psychiatric agents |
| 08/26/1997 | US5661183 Prevention or treatment of neurodegeneration |
| 08/26/1997 | US5661182 Binding hemoglobin with allosteric modifier in blood containing normal amounts of serum albumin |
| 08/26/1997 | US5661180 Administering to reduce levels of series ?2? while elevating the levels of series ?1? and series ?3? prostanoids; modulates metabolic response to trauma and disease states |
| 08/26/1997 | US5661179 Methods for treating neoplastic conditions using phenylacetic acid and derivatives thereof |
| 08/26/1997 | US5661178 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
| 08/26/1997 | US5661177 Zinc cysteate its preparation and uses in pharmacy and cosmetology |
| 08/26/1997 | US5661174 Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use |
| 08/26/1997 | US5661173 Administering an enzyme inhibitor treating diabetes |
| 08/26/1997 | US5661172 Administering a benzofuranyl imidazole compound for improving memory functions |
| 08/26/1997 | US5661171 Treating excessive intraocular pressure with reduced side effects by orally administering formulation of pilocarpine or salt in extended release carrier |
| 08/26/1997 | US5661169 1-benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and the pharmaceutical compositions containing them |
| 08/26/1997 | US5661168 Hypoglycemic agents |
| 08/26/1997 | US5661167 Memory enhancement, preventing or slowing the affect of amnesia or memory deficits |
| 08/26/1997 | US5661163 Treatment of benign prostatic hyperplasia |
| 08/26/1997 | US5661162 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists |
| 08/26/1997 | US5661161 Administering to treat cancer in mammals |
| 08/26/1997 | US5661159 Quinolylbenzofuran derivatives as leukotriene antagonists |
| 08/26/1997 | US5661158 Hypotensive agents, anticholesterol agents |
| 08/26/1997 | US5661157 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations |
| 08/26/1997 | US5661156 Administering to inhibit the growth of pathogenic fungi, to induce immunosuppression, and to treat carcinogenic tumors in humans and animals |
| 08/26/1997 | US5661155 Treatment of cancer with pharmaceutically active benzoquinazoline compounds |
| 08/26/1997 | US5661154 Oxypurinol alkali and alkaline earth salts in amorphorous or crystalline form as agents for treating hyperuricaemia and gout |
| 08/26/1997 | US5661151 Posaconazole and salts |
| 08/26/1997 | US5661150 Drug for neuroprotection |
| 08/26/1997 | US5661145 Treating or preventing atherosclerosis or reducing plasma cholesterol levels |
| 08/26/1997 | US5661143 Inhibits (de)polymerization of tubulin to form cellular microtubes; anticarcinogenic,-tumor, inflammatory and wound healing agents; immunology; angiogenesis inhibitors |
| 08/26/1997 | US5661142 Anti-emetic composition |
| 08/26/1997 | US5661141 19-oxygenated steroids as therapeutic agents |
| 08/26/1997 | US5661140 Treating psoriasis |
| 08/26/1997 | US5661138 (o-Acyl-p-N-acylamino-phenyl)-O-phosphoethanolamines |
| 08/26/1997 | US5661137 Antacid pharmaceutical composition in the form of a suspension based on sucralfate gel |
| 08/26/1997 | US5661136 2-halo-2'-fluoro ARA adenosines as antinoplastic agents |
| 08/26/1997 | US5661135 Human VEGF-specific oligonucleotides |
| 08/26/1997 | US5661131 Administering a vibrio toxin-binding oligosaccharide bound to an absorbent solid support by a nonpeptidyl spacer arm; elimination from the gastrointestinal tract |
| 08/26/1997 | US5661129 Organic nitrates containing a disulfide group as cardiovascular agents |
| 08/26/1997 | US5660976 Method for preserving a liver by perfusion with or storage in a solution containing ascorbyl tocopheryl phosphodiester |
| 08/26/1997 | US5660861 Effective therapy for epilepsies |
| 08/26/1997 | US5660860 Acyclovir in water dispersible tablet; herpes virus treatment |
| 08/26/1997 | US5660859 Gelation of low-molecular weight polymer in water using calcium acetate at room temperature; drug capsules; dental products; cosmetics; cariers |
| 08/26/1997 | US5660858 Cyclosporin emulsions |
| 08/26/1997 | US5660849 Kit comprising support for maintaining polymer thereon, means for compressing polymer, vials containing water coagulable thermoplastic polymer in water soluble organic solvent, aqueous medium |
| 08/26/1997 | US5660842 Administering at least one monoglyceride of fatty acid as bactericides |
| 08/26/1997 | US5660838 A xylobiose composition for reducing the roughness and dryness of human skin and hair |
| 08/26/1997 | US5660837 Preparing pharmaceutical formulation in form of oil-in-water emulsion |
| 08/26/1997 | US5660835 Method of treating adenosine depletion |
| 08/26/1997 | US5660833 Anti-tussive composition |
| 08/26/1997 | US5660830 Solvent extration with ethanol |
| 08/26/1997 | US5660829 Process for antibody directed enzyme prodrug therapy |
| 08/26/1997 | US5660824 Muscle trophic factor |
| 08/26/1997 | US5660823 Fast drying, film forming iodine release solution |
| 08/26/1997 | US5660813 Method of screening of angiotens in II type I receptor antagonists |
| 08/26/1997 | CA2149245C Novel isoxazolines as antiinflammatory agents |
| 08/26/1997 | CA2140344C Antiinflammatory indolinyl n-hydroxyurea and n-hydroxamic acid derivatives |
| 08/26/1997 | CA2111463C Azaspiro quinolone antibacterial agents |
| 08/26/1997 | CA2069931C Muscarinic receptor antagonists |
| 08/26/1997 | CA1339373C 6-7-disubstituted 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-c arboxylic acids |
| 08/26/1997 | CA1339368C Optically active compounds |
| 08/26/1997 | CA1339367C Purified hematoporphyrin trimers useful in photodynamic therapy |
| 08/26/1997 | CA1339345C Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive |
| 08/22/1997 | CA2198176A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/21/1997 | WO1997031000A1 Quinolones and their therapeutic use |
| 08/21/1997 | WO1997030178A2 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 08/21/1997 | WO1997030171A1 Polysaccharide precipitation process |
| 08/21/1997 | WO1997030159A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 08/21/1997 | WO1997030153A1 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas |